Meeting of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, 6201 [2018-02900]

Download as PDF Federal Register / Vol. 83, No. 30 / Tuesday, February 13, 2018 / Notices Meeting of the Presidential Advisory Council on Combating AntibioticResistant Bacteria Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. AGENCY: ACTION: Notice. As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that a meeting is scheduled to be held on March 2, 2018, for the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (Advisory Council). The meeting will be open to the public via teleconference; a public comment session will be held during the meeting. Pre-registration is required for members of the public who wish to attend the meeting via teleconference and who wish to participate in the public comment session. Individuals who wish to send in their public comment via email should send an email to CARB@hhs.gov. Registration information is available on the website http://www.hhs.gov/ash/carb/ and must be completed by February 26, 2018. Additional information about registering for the meeting and providing public comment can be obtained at http:// www.hhs.gov/ash/carb/ on the Meetings page. SUMMARY: The meeting is scheduled to be held on March 2, 2018, from 9:00 a.m. to 11:00 a.m. ET (times are tentative and subject to change). The confirmed times and agenda items for the meeting will be posted on the website for the Advisory Council at http://www.hhs.gov/ash/ carb/ when this information becomes available. Pre-registration for attending the meeting is required to be completed no later than February 26, 2018. DATES: Instructions regarding attending this meeting will be posted one week prior to the meeting at: http:// www.hhs.gov/ash/carb/. ADDRESSES: sradovich on DSK3GMQ082PROD with NOTICES FOR FURTHER INFORMATION CONTACT: Jomana Musmar, Acting Designated Federal Officer, Presidential Advisory Council on Combating AntibioticResistant Bacteria, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services, Room 715H, Hubert H. Humphrey Building, 200 Independence Avenue SW, Washington, DC 20201. Phone: (202) 690–5566; email: CARB@ hhs.gov. VerDate Sep<11>2014 23:12 Feb 12, 2018 Jkt 244001 Under Executive Order 13676, dated September 18, 2014, authority was given to the Secretary of HHS to establish the Advisory Council, in consultation with the Secretaries of Defense and Agriculture. Activities of the Advisory Council are governed by the provisions of Public Law 92–463, as amended (5 U.S.C. App.), which sets forth standards for the formation and use of federal advisory committees. The Advisory Council will provide advice, information, and recommendations to the Secretary of HHS regarding programs and policies intended to support and evaluate the implementation of Executive Order 13676, including the National Strategy for Combating Antibiotic-Resistant Bacteria and the National Action Plan for Combating Antibiotic-Resistant Bacteria. The Advisory Council shall function solely for advisory purposes. In carrying out its mission, the Advisory Council will provide advice, information, and recommendations to the Secretary regarding programs and policies intended to preserve the effectiveness of antibiotics by optimizing their use; advance research to develop improved methods for combating antibiotic resistance and conducting antibiotic stewardship; strengthen surveillance of antibioticresistant bacterial infections; prevent the transmission of antibiotic-resistant bacterial infections; advance the development of rapid point-of-care and agricultural diagnostics; further research on new treatments for bacterial infections; develop alternatives to antibiotics for agricultural purposes; maximize the dissemination of up-todate information on the appropriate and proper use of antibiotics to the general public and human and animal healthcare providers; and improve international coordination of efforts to combat antibiotic resistance. The public meeting will be dedicated to the Advisory Council’s deliberation and vote on a letter drafted by the Immediate Action Subcommittee. The meeting agenda will be posted on the Advisory Council website at http:// www.hhs.gov/ash/carb/ when it has been finalized. All agenda items are tentative and subject to change. Instructions regarding attending this meeting will be posted one week prior to the meeting at: http://www.hhs.gov/ ash/carb/. Members of the public will have the opportunity to provide comments prior to the Advisory Council meeting by emailing CARB@hhs.gov. Public comments should be sent in by midnight February 26, 2018, and should SUPPLEMENTARY INFORMATION: DEPARTMENT OF HEALTH AND HUMAN SERVICES PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 6201 be limited to no more than one page. All public comments received prior to February 26, 2018, will be provided to Advisory Council members; comments are limited to two minutes per speaker. Dated: February 7, 2018. Jomana F. Musmar, Acting Designated Federal Officer, Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, Committee Manager. [FR Doc. 2018–02900 Filed 2–12–18; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; NIDDK Research Project Grants. Date: March 5, 2018. Time: 4:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Elena Sanovich, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7351, 6707 Democracy Boulevard, Bethesda, MD 20892–2542, 301–594–8886, sanoviche@mail.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; NIDDK R01–A1 Telephone SEP. Date: March 6, 2018. Time: 11:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). E:\FR\FM\13FEN1.SGM 13FEN1

Agencies

[Federal Register Volume 83, Number 30 (Tuesday, February 13, 2018)]
[Notices]
[Page 6201]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-02900]



[[Page 6201]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Presidential Advisory Council on Combating 
Antibiotic-Resistant Bacteria

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that a meeting is scheduled to be held on March 2, 2018, for the 
Presidential Advisory Council on Combating Antibiotic-Resistant 
Bacteria (Advisory Council). The meeting will be open to the public via 
teleconference; a public comment session will be held during the 
meeting. Pre-registration is required for members of the public who 
wish to attend the meeting via teleconference and who wish to 
participate in the public comment session. Individuals who wish to send 
in their public comment via email should send an email to [email protected]. 
Registration information is available on the website http://www.hhs.gov/ash/carb/ and must be completed by February 26, 2018. 
Additional information about registering for the meeting and providing 
public comment can be obtained at http://www.hhs.gov/ash/carb/ on the 
Meetings page.

DATES: The meeting is scheduled to be held on March 2, 2018, from 9:00 
a.m. to 11:00 a.m. ET (times are tentative and subject to change). The 
confirmed times and agenda items for the meeting will be posted on the 
website for the Advisory Council at http://www.hhs.gov/ash/carb/ when 
this information becomes available. Pre-registration for attending the 
meeting is required to be completed no later than February 26, 2018.

ADDRESSES: Instructions regarding attending this meeting will be posted 
one week prior to the meeting at: http://www.hhs.gov/ash/carb/.

FOR FURTHER INFORMATION CONTACT: Jomana Musmar, Acting Designated 
Federal Officer, Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria, Office of the Assistant Secretary for Health, U.S. 
Department of Health and Human Services, Room 715H, Hubert H. Humphrey 
Building, 200 Independence Avenue SW, Washington, DC 20201. Phone: 
(202) 690-5566; email: [email protected].

SUPPLEMENTARY INFORMATION: Under Executive Order 13676, dated September 
18, 2014, authority was given to the Secretary of HHS to establish the 
Advisory Council, in consultation with the Secretaries of Defense and 
Agriculture. Activities of the Advisory Council are governed by the 
provisions of Public Law 92-463, as amended (5 U.S.C. App.), which sets 
forth standards for the formation and use of federal advisory 
committees.
    The Advisory Council will provide advice, information, and 
recommendations to the Secretary of HHS regarding programs and policies 
intended to support and evaluate the implementation of Executive Order 
13676, including the National Strategy for Combating Antibiotic-
Resistant Bacteria and the National Action Plan for Combating 
Antibiotic-Resistant Bacteria. The Advisory Council shall function 
solely for advisory purposes.
    In carrying out its mission, the Advisory Council will provide 
advice, information, and recommendations to the Secretary regarding 
programs and policies intended to preserve the effectiveness of 
antibiotics by optimizing their use; advance research to develop 
improved methods for combating antibiotic resistance and conducting 
antibiotic stewardship; strengthen surveillance of antibiotic-resistant 
bacterial infections; prevent the transmission of antibiotic-resistant 
bacterial infections; advance the development of rapid point-of-care 
and agricultural diagnostics; further research on new treatments for 
bacterial infections; develop alternatives to antibiotics for 
agricultural purposes; maximize the dissemination of up-to-date 
information on the appropriate and proper use of antibiotics to the 
general public and human and animal healthcare providers; and improve 
international coordination of efforts to combat antibiotic resistance.
    The public meeting will be dedicated to the Advisory Council's 
deliberation and vote on a letter drafted by the Immediate Action 
Subcommittee. The meeting agenda will be posted on the Advisory Council 
website at http://www.hhs.gov/ash/carb/ when it has been finalized. All 
agenda items are tentative and subject to change.
    Instructions regarding attending this meeting will be posted one 
week prior to the meeting at: http://www.hhs.gov/ash/carb/.
    Members of the public will have the opportunity to provide comments 
prior to the Advisory Council meeting by emailing [email protected]. Public 
comments should be sent in by midnight February 26, 2018, and should be 
limited to no more than one page. All public comments received prior to 
February 26, 2018, will be provided to Advisory Council members; 
comments are limited to two minutes per speaker.

    Dated: February 7, 2018.
Jomana F. Musmar,
Acting Designated Federal Officer, Presidential Advisory Council on 
Combating Antibiotic-Resistant Bacteria, Committee Manager.
[FR Doc. 2018-02900 Filed 2-12-18; 8:45 am]
 BILLING CODE 4150-44-P